CompletedNCT01731119
Weight Changes With Lurasidone in Children and Teens Starting Antipsychotic Treatment
About this title
Read the official source — NCT01731119Medication studyAges 6–19United StatesSchizophrenia
Understand this study
Who was this study for?
Listed age limits: 6 years to 19 years.
- Listed locations
- Chapel HillSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateDecember 2012
- Recruitment status
- Completed
- Enrollment listed in the registry
- 9
- Sponsor
- University of North Carolina, Chapel Hill
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 6 Years to 19 Years
- Official registry ID
- NCT01731119
- Official title
Show the full official title
An Open-Label Pilot Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Chapel Hill
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of North Carolina, Chapel Hill, a university.
Did this study involve medication?
Yes. The study involved medication, including Latuda©.
Who was this study for?
Listed age limits: 6 years to 19 years.
